• br Clinical Genitourinary Cancer June e br Survival Rates

  2022-09-17

  

  Clinical Genitourinary Cancer June 2019 - e491 Survival Rates for Definitive and Non-Definitive Therapy of Muscle-Invasive Bladder Cancer findings may overestimate the survival benefit of DT. Moreover, by grouping all forms of DT, we potentially underestimated the survival benefit of specifi

• br Contesini M Guberti M Saccani

  2022-09-17

  

  [5] Contesini M, Guberti M, Saccani R, Braglia L, Iotti C, Botti A, et al. Setup errors in patients with head-neck cancer (HNC), treated using the intensity modulated radiation therapy (IMRT) technique: how it influences the cus-tomised immobilisation systems, patient’s pain and anxiety. Radiat

• br RatioAspect ObjectWidth br ObjectLength br Histogram is worked by

  2022-09-17

  

   RatioAspect ¼ ObjectWidth ð9Þ ObjectLength Histogram is worked by calculating the spread of intensity value. Histogram has some features used to describe texture pat-tern of image. This study used eight features for representing tex-ture pattern. These were mean, standard deviation, ske

• br Conclusions We identified the circRNA expression profile in

  2022-09-17

  

  Conclusions: We identified the circRNA Cyclosporin H profile in ovarian cancer tissues and further verified the existence and expression of six randomly selected differentially expressed circRNAs. Besides, we also found that circHIPK3 is an important regulator of ovarian cancer progression. 1.

• br E F is found highly expressed in several

  2022-09-17

  

  E2F5 is found highly expressed in several tumors, such as glioblas-toma,40 and prostate cancer.41 Downregulation of E2F5 was also  found in MCF7 cells, and it significantly inhibited cell proliferation, migration, and invasion and increased cell-cycle arrest at the G0/G1 stage in vitro.23 Mor

• br Others br Charlson comorbidity index n br

  2022-09-16

  

  Others Charlson comorbidity index, n (%) Hospital annual volume, n (%) Low Medium High Northeast Midwest South West Teaching Non-teaching Insurance status, n (%) Private Medicare Medicaid Other Large Medium Small First Quartile Second

• br propensity matched patients treated with definitive

  2022-09-16

  

   propensity-matched patients treated with definitive CRT and were 71.15%, 56.50%, and 46.17%, respectively, for propensity-matched patients treated with esophagectomy alone (p Conclusions. Esophagectomy alone could provide bet-ter survival than definitive CRT for patients with clinical stage I

• br BAX Bcl ratio is

  2022-09-15

  

  3.3. BAX/Bcl-2 ratio is static in SIM- and MET-treated endometrial cancer cells To characterize the apoptotic mechanism, RL95-2 Cycloheximide treated with 1 μM SIM, 4 mM MET, or the combination for 48 h were tested by west-ern immunoblotting of BAX and Bcl-2 proteins as this pathway has been i

• br DISCUSSION br In this study

  2022-09-15

  

   DISCUSSION In this study, we evaluated the effect of combination therapy with ce-tuximab and the oncolytic herpes virus C-REV on human CRC cell lines and tumor xenografts. Cell viability assays revealed that the cyto-toxicity of C-REV was time and dose dependent (Figure 2A). Viral LY3009120

• br Woerther PL Burdet C Chachaty E Andremont A Trends

  2022-09-15

  

  18. Woerther PL, Burdet C, Chachaty E, Andremont A. Trends in human fecal carriage of extended-spectrum b-lactamases in the community: toward the globalization of CTX-M. Clin Microbiol Rev 2013;26:744-58. 19. Melzer M, Petersen I. Mortality following bacteraemic infection caused by extended spect

• br EGFR a transmembrane tyrosine

  2022-09-14

  

  EGFR, a transmembrane tyrosine kinase, transmits important  growth factor signals of the extracellular milieu into cells. More than 60% of NSCLCs express EGFR, which is an important therapeutic target for the treatment of NSCLCs [47,48]. CAP and iron oxide-based MNPs either individually or in

• br The activity of the RhoA protein was determined

  2022-09-14

  

  The activity of the RhoA protein was determined using a pull-down assay (Thermo Fisher Scientific, #89854) according to the manufac-turer's instructions. HT-29 RNase Inhibitor were seeded in a T-25 flask with DMEM + 10% FBS. Upon reaching about 80% confluence, the assay was performed. Rhotekin RBD

• br Corresponding author br to recur

  2022-09-14

  

  Corresponding author. to recur in an untreatable form. There are different chemotherapy resistance mechanisms but very often resistance develops when the cancer cells start to over express genes that disable or exclude the chemotherapy drugs. A common method is for cancer cells to over expre

• br proportional hazards regression models were used

  2022-09-13

  

  proportional hazards regression models were used for the unadjusted univariate and adjusted multivariate survival analyses. Proportionality assumptions for the Cox regression models were tested, as well as Schoenfeld residuals plots for each subsite location over time. Variables and pairwise inter

• Erastin br In patients who received

  2022-09-13

  

  In patients who received neoadjuvant therapy, any pathologic response was predictive of a significantly decreased risk of death (0.82, 95%CI 0.75-0.92). This held true across all stages (Supplementary Table 1). Compared to accurately staged patients, patients who were understaged had increased ris

175 records 1/12 page Next 12345 Next 5 pages Last page